Published in Biochemistry on February 20, 1979
Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol (1985) 5.73
Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci U S A (1981) 4.26
Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol (1984) 3.53
The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J Virol (1995) 3.16
In vivo control of NF-kappa B activation by I kappa B alpha. EMBO J (1993) 3.11
Localization of epitopes of herpes simplex virus type 1 glycoprotein D. J Virol (1985) 2.71
A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A (2000) 2.40
Localization of the adenovirus E1Aa protein, a positive-acting transcriptional factor, in infected cells infected cells. Mol Cell Biol (1983) 2.36
A major glycoprotein of the nuclear pore complex is a membrane-spanning polypeptide with a large lumenal domain and a small cytoplasmic tail. EMBO J (1990) 2.28
Topology of the 32-kd liver gap junction protein determined by site-directed antibody localizations. EMBO J (1988) 2.26
Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc Natl Acad Sci U S A (1989) 2.25
Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein. Proc Natl Acad Sci U S A (1985) 2.23
Functional organization of the retrotransposon Ty from Saccharomyces cerevisiae: Ty protease is required for transposition. Mol Cell Biol (1988) 1.92
One of three transmembrane stretches is sufficient for the functioning of the SecE protein, a membrane component of the E. coli secretion machinery. EMBO J (1991) 1.89
B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect Immun (1998) 1.86
Distinct subsets of retroviruses encode dUTPase. J Virol (1992) 1.80
Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies. Proc Natl Acad Sci U S A (1985) 1.79
Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. J Virol (1987) 1.77
A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci U S A (1986) 1.74
Processing pathway for protease B of Saccharomyces cerevisiae. J Cell Biol (1989) 1.68
The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers. Mol Cell Biol (1995) 1.64
Fine structure analysis of type-specific and type-common antigenic sites of herpes simplex virus glycoprotein D. J Virol (1984) 1.63
Immunocytochemical detection of interleukin 1 within stimulated human monocytes. J Exp Med (1986) 1.57
Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol (1988) 1.57
Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences. J Cell Biol (1992) 1.54
Proteolytic processing of pol-TYB proteins from the yeast retrotransposon Ty1. J Virol (1991) 1.53
Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. Proc Natl Acad Sci U S A (1989) 1.52
Anti-hypervariable region antibody induced by a defined peptide: an approach for studying the structural correlates of idiotypes. Proc Natl Acad Sci U S A (1984) 1.50
Specific targeting of membrane nodulins to the bacteroid-enclosing compartment in soybean nodules. EMBO J (1985) 1.48
Characterization of a transpositionally active Ty3 element and identification of the Ty3 integrase protein. J Virol (1990) 1.47
Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus. J Virol (1993) 1.46
Mapping a new gene that encodes an 11,600-molecular-weight protein in the E3 transcription unit of adenovirus 2. J Virol (1984) 1.43
B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus. J Virol (1988) 1.42
Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame. J Virol (1988) 1.42
Expression of NFAT-family proteins in normal human T cells. Mol Cell Biol (1997) 1.41
Delineation of a cross-reactive idiotype on human autoantibodies with antibody against a synthetic peptide. J Exp Med (1984) 1.40
Peptides as antigens. Importance of orientation. J Exp Med (1986) 1.39
Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans. J Clin Invest (1988) 1.38
Human adenovirus 2 E1B-19K and E1B-53K tumor antigens: antipeptide antibodies targeted to the NH2 and COOH termini. J Virol (1983) 1.38
Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J Virol (1992) 1.38
Influence of protein flexibility and peptide conformation on reactivity of monoclonal anti-peptide antibodies with a protein alpha-helix. Proc Natl Acad Sci U S A (1987) 1.34
Characterization of an epibody. An antiidiotype that reacts with both the idiotype of rheumatoid factors (RF) and the antigen recognized by RF. J Exp Med (1985) 1.32
Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain. J Cell Biol (1991) 1.30
Antibody mapping of tissue factor implicates two different exon-encoded regions in function. Biochem J (1991) 1.30
Recent studies on the regulation of IgE antibody synthesis in experimental animals and man. Immunology (1980) 1.28
Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression. J Virol (1988) 1.26
Structure, expression and chromosomal localization of human p80-coilin gene. Nucleic Acids Res (1994) 1.24
Ty3 GAG3 and POL3 genes encode the components of intracellular particles. J Virol (1992) 1.23
Characterization of two related Epstein-Barr virus-encoded membrane proteins that are differentially expressed in Burkitt lymphoma and in vitro-transformed cell lines. Proc Natl Acad Sci U S A (1986) 1.22
Glucose repression of the yeast ADH2 gene occurs through multiple mechanisms, including control of the protein synthesis of its transcriptional activator, ADR1. Mol Cell Biol (1992) 1.21
Transposition of the yeast retroviruslike element Ty3 is dependent on the cell cycle. Mol Cell Biol (1994) 1.19
Expression of human beta-defensin 2 (hBD-2) in Helicobacter pylori induced gastritis: antibacterial effect of hBD-2 against Helicobacter pylori. Gut (2001) 1.16
Variable region diversity in human circulating antibodies specific for the capsular polysaccharide of Haemophilus influenzae type b. Preferential usage of two types of VH3 heavy chains. J Clin Invest (1991) 1.15
Characterization of human rheumatoid factors with seven antiidiotypes induced by synthetic hypervariable region peptides. J Exp Med (1985) 1.14
Studies on the expression of the pufX polypeptide and its requirement for photoheterotrophic growth in Rhodobacter sphaeroides. EMBO J (1992) 1.13
A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proc Natl Acad Sci U S A (1989) 1.13
Site-specific antibodies against the PrlA (secY) protein of Escherichia coli inhibit protein export by interfering with plasma membrane binding of preproteins. Proc Natl Acad Sci U S A (1989) 1.11
Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity. Proc Natl Acad Sci U S A (1991) 1.08
Structure of the hepatitis A virion: peptide mapping of the capsid region. J Virol (1986) 1.08
Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP. J Virol (1990) 1.07
Indirect immunofluorescence localization of beta-adrenergic receptors and G-proteins in human A431 cells. Biochem J (1989) 1.06
Testis-specific mak protein kinase is expressed specifically in the meiotic phase in spermatogenesis and is associated with a 210-kilodalton cellular phosphoprotein. Mol Cell Biol (1993) 1.05
Localization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies. J Virol (1987) 1.04
The galactosyl-(alpha 1-4)-galactose-binding adhesin of Streptococcus suis: occurrence in strains of different hemagglutination activities and induction of opsonic antibodies. Infect Immun (1996) 1.03
Human placental syncytiotrophoblastic Mr 75,000 polypeptide defined by antibodies to a synthetic peptide based on a cloned human endogenous retroviral DNA sequence. Proc Natl Acad Sci U S A (1984) 1.03
Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus. J Virol (1988) 1.03
Cloning and sequence determination of a human rheumatoid factor light-chain gene. Proc Natl Acad Sci U S A (1986) 1.02
Production of antibody to and cellular localization of erythrocyte-sensitizing substance from Rickettsia rickettsii. J Clin Microbiol (1989) 1.01
Structural analysis of the human papillomavirus type 16-E2 transactivator with antipeptide antibodies reveals a high mobility region linking the transactivation and the DNA-binding domains. Nucleic Acids Res (1991) 1.01
Sequence of the phosphoprotein gene of pneumonia virus of mice: expression of multiple proteins from two overlapping reading frames. J Virol (1994) 1.01
A subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulfide-bonded loop. J Virol (1990) 0.99
Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction. J Virol (1999) 0.99
Antibodies of predetermined specificity against chemically synthesized peptides of human interleukin 2. Proc Natl Acad Sci U S A (1984) 0.98
Anti-HLA antibodies of predetermined specificity: a chemically synthesized peptide induces antibodies specific for HLA-A,B heavy chain. Proc Natl Acad Sci U S A (1983) 0.97
Identification of a multifunctional, cell-binding peptide sequence from the a1(NC1) of type IV collagen. J Cell Biol (1990) 0.96
Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest (1989) 0.95
Identification of staphylococcal enterotoxin B sequences important for induction of lymphocyte proliferation by using synthetic peptide fragments of the toxin. Infect Immun (1994) 0.93
Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro. J Virol (1988) 0.93
Human major histocompatibility complex class I antigens: residues 61-83 of the HLA-B7 heavy chain specify an alloreactive site. Proc Natl Acad Sci U S A (1985) 0.92
Induction of antibodies to the envelope protein of the human immunodeficiency virus by immunization with monoclonal anti-idiotypes. Proc Natl Acad Sci U S A (1991) 0.91
Rabies ribonucleocapsid as an oral immunogen and immunological enhancer. Proc Natl Acad Sci U S A (1994) 0.90
Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1. J Virol (1990) 0.89
Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. Immunology (1992) 0.88
Mapping an antibody-binding site and a T-cell-stimulating site on the 1A protein of respiratory syncytial virus. J Virol (1988) 0.88
Vaccination against lethal coronavirus-induced encephalitis with a synthetic decapeptide homologous to a domain in the predicted peplomer stalk. J Virol (1988) 0.88
Identification and functional differentiation of two type I fatty acid synthases in Brevibacterium ammoniagenes. J Bacteriol (1996) 0.87
Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides. Infect Immun (1992) 0.87
Binding of cystatin C to C4: the importance of sense-antisense peptides in their interaction. Proc Natl Acad Sci U S A (1990) 0.87
Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenza virus. J Virol (1997) 0.86
The role of serum factors in the suppression of experimental allergic encephalomyelitis: evidence for immunoregulation by antibody to the encephalitogenic peptide. Immunology (1990) 0.86
Chemical synthesis of idiotopes. Evidence that antisera to the same JH1 peptide detect multiple binding site-associated idiotopes. J Exp Med (1984) 0.85
Identification of a functionally conserved surface region of rat cytochromes P450IA. Biochem J (1991) 0.83
An anti-peptide antibody targeted to a specific region of rat cytochrome P-450IA2 inhibits enzyme activity. Biochem J (1990) 0.81
Expression of P30, a protein with adhesive properties, in Schwann cells and neurons of the developing and regenerating peripheral nerve. J Cell Biol (1991) 0.81
Role of hypoxia-inducible factor α in response to hypoxia and heat shock in the Pacific oyster Crassostrea gigas. Mar Biotechnol (NY) (2011) 0.81
Coupling of nonpolymerizable monomeric actin to the F-actin binding region of the myosin head. Proc Natl Acad Sci U S A (1989) 0.81
Immunological tolerance to allergenic protein determinants: a therapeutic approach for selective inhibition of IgE antibody production. Proc Natl Acad Sci U S A (1979) 0.80
Epitope mapping of B-cell determinants on the 15-kilodalton lipoprotein of Treponema pallidum (Tpp15) with synthetic peptides. Infect Immun (1996) 0.80
Identification of a T cell-derived b cell growth factor distinct from interleukin 2. J Exp Med (1982) 9.49
The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol (1972) 9.43
Cell interactions between histoincompatible T and B lymphocytes. VII. Cooperative responses between lymphocytes are controlled by genes in the I region of the H-2 complex. J Exp Med (1975) 7.64
Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol (1980) 6.69
The function and interrelationships of T-cell receptors, Ir genes and other histocompatibility gene products. Transplant Rev (1975) 5.88
Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization. J Exp Med (1970) 5.71
Critical role of determinant presentation in the induction of specific responses in immunocompetent lymphocytes. J Exp Med (1973) 5.30
The allogeneic effect on immune responses: model for regulatory influences of T lymphocytes on the immune system. Transplant Rev (1972) 5.23
The allogeneic effect in inbred mice. II. Establishment of the cellular interactions required for enhancement of antibody production by the graft-versus-host reaction. J Exp Med (1972) 4.70
Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene product. Nature (1980) 4.35
Carrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactions. J Exp Med (1971) 4.29
Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci U S A (1981) 4.26
Cell interactions between histoincompatible T and B lymphocytes. The H-2 gene complex determines successful physiologic lymphocyte interactions. Proc Natl Acad Sci U S A (1973) 4.12
Cell interactions between histoincompatible T and B lymphocytes. IV. Involvement of the immune response (Ir) gene in the control of lymphocyte interactions in responses controlled by the gene. J Exp Med (1973) 4.05
Activation of T and B lymphocytes in vitro. II. Biological and biochemical properties of an allogeneic effect factor (AEF) active in triggering specific B lymphocytes. J Exp Med (1974) 3.54
Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor. J Exp Med (1974) 3.29
Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J Exp Med (1981) 3.27
Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med (1990) 3.05
Antigen-induced T cell-replacing factor (TRF). III. Establishment of T cell hybrid clone continuously producing TRF and functional analysis of released TRF. J Immunol (1980) 2.95
Activation of T and B lymphocytes in vitro. I. Regulatory influence of bacterial lipopolysaccharide (LPS) on specific T-cell helper function. J Exp Med (1974) 2.90
Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A (1996) 2.85
Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol (1988) 2.80
The histocompatibility-linked immune response genes. Adv Cancer Res (1975) 2.64
Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon. J Immunol (1983) 2.61
Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responses. J Exp Med (1970) 2.54
Cell interactions between histoincompatible T and B lymphocytes. I. Allogeneic effect by irradiated host T cells on adoptively transferred histoincompatible B lymphocytes. J Exp Med (1973) 2.49
Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol (2000) 2.40
Radioresistance of carrier-specific helper thymus-derived lymphocytes in mice. Proc Natl Acad Sci U S A (1972) 2.35
Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol (2001) 2.12
Regulation of mast cell survival by IgE. Immunity (2001) 2.11
Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol (2000) 2.06
Radioresistance of cooperative function of carrier-specific lymphocytes in antihapten antibody responses. Science (1970) 2.03
Recovery from exercise-induced desaturation in the quadriceps muscles of elite competitive rowers. Am J Physiol (1992) 2.02
The allogeneic effect in inbred mice. I. Experimental conditions for the enhancement of hapten-specific secondary antibody responses by the graft-versus-host reaction. J Exp Med (1972) 1.99
Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages. Cancer Res (1997) 1.94
Hapten-specific IgE antibody responses in mice. I. Secondary IgE responses in irradiated recipients of syngeneic primed spleen cells. J Exp Med (1973) 1.87
Immunological tolerance in bone marrow-derived lymphocytes. I. Evidence for an intracellular mechanism of inactivation of hapten-specific precursors of antibody-forming cells. J Exp Med (1972) 1.86
The allergic phenotype: manifestation of 'allergic breakthrough' and imbalance in normal 'damping' of IgE antibody production. Immunol Rev (1978) 1.83
Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor. J Exp Med (1982) 1.81
Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology (1997) 1.80
Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J Exp Med (2001) 1.74
Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes. J Exp Med (1982) 1.73
Induction of B cell differentiation by T cell factors. I. Stimulation of IgM secretion by products of a T cell hybridoma and a T cell line. J Immunol (1981) 1.73
Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma. Proc Natl Acad Sci U S A (1983) 1.73
A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J Immunol (1999) 1.69
Purification and physicochemical characterization of murine T cell replacing factor (TRF). J Immunol (1985) 1.67
Cellular site of action of various adjuvants in antibody responses to hapten-carrier conjugates. J Immunol (1973) 1.62
A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J Immunol (1997) 1.58
Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol (1996) 1.58
Hapten-specific IgE antibody responses in mice. IV. Evidence for distinctive sensitivities of IgE and IgG B lymphocytes to the regulatory influence of T cells. J Immunol (1974) 1.57
IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. J Exp Med (1983) 1.56
Hapten-specific IgE antibody responses in mice. II. Cooperative interactions between adoptively transferred T and B lymphocytes in the development of IgE response. J Exp Med (1973) 1.55
Control of t-lymphocyte and B-lymphocyte activation by two complementing Ir-GLphi immune response genes. J Exp Med (1976) 1.52
Cell interactions between histoincompatible T and B lymphocytes. V. Failure of histoincompatible T cells to interfere with physiologic cooperation between syngeneic T and B lymphocytes. J Immunol (1974) 1.51
Antigen-induced T cell-replacing factor (TRF). I. Functional characterization of a TRF-producing helper T cell subset and genetic studies on TRF production. J Immunol (1980) 1.51
Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis. J Exp Med (1984) 1.51
Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin. J Biol Chem (1992) 1.49
Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer (1999) 1.46
Soluble factors involved in B cell differentiation: identification of two distinct T cell-replacing factors (TRF). J Immunol (1983) 1.46
Induction of B cell tolerance in vitro to 2,4-dinitrophenyl coupled to a copolymer of D-glutamic acid and D-lysine (DNP-D-GL). J Exp Med (1973) 1.45
Patterns of immune reactivity in autoimmune murine strains. I. Cell-mediated immune responses induced by H-2 indentical and H-2 incompatible stimulator cells. J Immunol (1979) 1.43
Ferritin, a Hodgkin's disease associated antigen. Proc Natl Acad Sci U S A (1974) 1.43
Resistance of guinea pigs to leukemia following transfer of immunocompetent allogeneic lymphoid cells. Cancer Res (1972) 1.42
Galectins in cell growth and apoptosis. Cell Mol Life Sci (2003) 1.41
The role of the histocompatibilty gene complex in lymphocyte defferetiation. Cold Spring Harb Symp Quant Biol (1977) 1.41
Hapten-specific IgE antibody responses in mice. VII. Conversion of IgE "non-responder" strains to IgE "responders" by elimination of suppressor T cell activity. J Immunol (1977) 1.40
Cell interactions between histoincompatible T and B lymphocytes. VIII. In vivo cooperative responses between lymphocytes are controlled by genes in the K-end of the H-2 complex. J Immunol (1975) 1.40
Antigen-specific immunocompetency, B cell function, and regulatory helper and suppressor T cell activities in spontaneously autoimmune mice. J Immunol (1979) 1.39
Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med (1995) 1.38
Hapten-specific IgE antibody responses in mice. VI. Selective enhancement of IgE antibody production by low doses of X-irradiation and by cyclophosphamide. J Immunol (1976) 1.36
A human lectin, galectin-3 (epsilon bp/Mac-2), stimulates superoxide production by neutrophils. J Immunol (1995) 1.35
The allogeneic effect in inbred mice. 3. Unique antigenic structural requirements in the expression of the phenomenon on unprimed cell populations in vivo. J Exp Med (1973) 1.35
Isolation and characterization of human VkIII germ-line genes. Implications for the molecular basis of human VkIII light chain diversity. J Immunol (1987) 1.35
Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer (2000) 1.33
Near-infrared spectroscopy: what can it tell us about oxygen saturation in skeletal muscle? Exerc Sport Sci Rev (2000) 1.32
Induction of T-lymphocyte responses to a small molecular weight antigen. III. T-T cell interactions to determinants linked together: suppression vs. enhancement. J Exp Med (1975) 1.32
Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. J Immunol (1992) 1.32
Hapten-specific tolerance. Preferential depression of the high affinity antibody response. J Exp Med (1972) 1.31
Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3. Am J Pathol (1996) 1.30
Mechanisms involved in the antileukemic effect of immunocompetent allogeneic lymphoid cell transfer. Cancer Res (1972) 1.30